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Abstract
There is increasing evidence for a crucial role of proteases and metalloproteinases during axon growth and guidance. In this
context, we recently described a functional link between the chemoattractive Sema3C and Matrix metalloproteinase 3
(MMP3). Here, we provide data demonstrating the involvement of MMP-2 to trigger the growth-promoting effect of
Sema3A in cortical dendrites. The in situ analysis of MMP-2 expression and activity is consistent with a functional growth
assay demonstrating in vitro that the pharmacological inhibition of MMP-2 reduces the growth of cortical dendrites in
response to Sema3A. Hence, our results suggest that the selective recruitment and activation of MMP-2 in response to
Sema3A requires a PKC alpha dependent mechanism. Altogether, we provide a second set of data supporting MMPs as
effectors of the growth-promoting effects of semaphorins, and we identify the potential signalling pathway involved.
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Introduction
Several families of guidance molecules including eph/ephrins
[1,2], netrins [3], slits [4] and semaphorins [5,6] have been
identified over the past ten years. These secreted or membrane
anchored signals have growth promoting or growth inhibitory
properties leading to the appropriate orientation of process
outgrowth [7]. The mechanisms initially described for axon
guidance have now been shown also to control dendritic growth
and guidance [8] consistently with the many roles described for
semaphorins [9]. This is particularly the case for class 3
semaphorins which are key regulators of cortical wiring [10,11].
Once they reach their laminar position in the nascent cortical
plate, layer V and VI cortical neurons extend long axonal
projections to the thalamus or the spinal cord. Gradients of
Sema3A are thought to repel these cortical efferent fibers away
from the ventricular zone to reach the internal capsule [10,11].
Surprisingly, Sema3A has also been shown to control the dendritic
development of cortical neurons. This unexpected effect is
particularly striking because Sema3A acts on dendrites as a
growth promoter instead of triggering its classical inhibitory effect
[12,13]. The dual function of Sema3A in cortical neurons appears
to be linked to sub-cellular differences in cGMP localization [12].
The soluble form of the adhesion molecule L1 has also been shown
to convert the chemorepulsive effect of Sema3A into a
chemoattractive one [14]. The most detailed pathway of the
growth promoting effect of semaphorins has been recently
obtained during the molecular dissection of the Sema3B-
dependent positioning of the anterior commissure. In this study
the selective recruitment of the focal adhesion kinase (FAK) and
the activation of the Src kinase family were shown to define the
attractive effect of Sema3B [15]. Nevertheless, the exact nature of
the signalling cascade encoding the growth promoting activity of
semaphorins remains obscure. In search for signalling elements of
the semaphorin growth promoting pathways, we recently
identified a functional interaction between Sema3C and matrix
metalloproteinases (MMPs) [6]. The MMPs are proteolytic
enzymes ensuring various functions ranging from cell proliferation
and migration to cell surface receptor cleavage [16]. Our results
demonstrated that MMP-3 (stromelysin-1) is expressed and
activated in growing cortical axons. Strikingly, Sema3C increases
both the expression and activity of MMP-3, and the chemoat-
tractive effect of Sema3C is abolished by a specific inhibitor of
MMP-3. The chemorepulsive Sema3A was shown to reduce
MMP-3 expression and activity consistently with its inhibitory
effect on axons. Thus, similarly to what has been described for
ephrins [17] and netrins [18], a metalloproteinase activity is
required to achieve the appropriate signalling of semaphorins. To
characterize further the role of MMPs during corticogenesis and
semaphorin signalling we decided to search for a role of MMPs in
the chemoattractive effect of Sema3A on cortical neuron
dendrites. Our results demonstrate that the growth promoting
PLoS ONE | www.plosone.org 1 April 2009 | Volume 4 | Issue 4 | e5099effect of Sema3A on cortical dendrites requires MMP-2 by a
mechanism of transduction implicating at least neuropilin-1 and a
PKCa-dependent pathway.
Results
A gelatinolytic activity is detected in the developing
cortex
To address the potential role of MMPs during development of
cortical dendrites we searched for the existence of a gelatinolytic
activity in the developing E15 cortex. Using in situ zymography we
found a strong activity of gelatinases in the entire neocortex
(Figure 1). Both dividing cells of the ventricular zone and
differentiated cells of the cortical plates showed a capacity to
degrade FITC-conjugated gelatin. We verified the specificity of the
signal by addition of ortho-phenantroline that suppresses fluores-
cent signal. Strikingly, the addition of a MMP-2/9 (Gelatinase A
and B) inhibitor induced a significant reduction of the gelatinolytic
activity thereby supporting a role of these proteins in the observed
global enzymatic activity. The combination of in situ zymography
and immunostaining of the dendritic MAP2 marker showed that
such a gelatinolytic activity is present at the level of cortical
dendrites. This result is consistent with a role of MMPs during
cortical development, including dendritogenesis. These data were
obtained from collections of 8 different brains from which 5
different slices were analyzed (coronal sections, observation at the
telencephalon/diencephalon border).
Developing cortical dendrites express MMP-2
To investigate the potential role of gelatinases during cortical
dendrite development we investigated the expression of gelatinases
in the developing cortex. Using RT-PCR, we searched for the
presence of transcripts of the two classical gelatinases MMP-2 and
MMP-9 in the full brain (5 samples), in micro-dissected neocortex
(.25 samples) and in cultured cortical neurons (4 different
cultures). As depicted in Figure 2 showing the results of
representative samples, the two MMPs are expressed in all
conditions. We noticed that MMP-9 expression was weaker in
cultured neurons. Interestingly, cortical neurons also expressed
significant levels of Sema3A mRNA (Figure 2B). To address the
cellular expression of MMP-2 and MMP-9, we performed in situ
immunocytochemical analyses on samples taken from the
collection used for in situ zymography (with a minimum of 5
slices per conditions). Specific antibodies to MMP-2 and MMP-9
in combination with anti-MAP2 antibody allowed us to search for
the expression of the two gelatinases in cortical dendrites. As seen
in Figure 3, confocal microscopic analysis showed weak staining of
MMP-9 in cortical neurons with no obvious co-localisation with
the dendritic MAP2 marker. On the other hand, these neurons
express a high level of MMP-2, particularly in the apical dendrite.
This result is in favour of a role of MMP-2 in cortical neuron
dendritic outgrowth. Together with the in situ zymography, this
observation prompted us to examine whether MMP-2 expression
varied in response to Sema3A.
The Sema3A-dependent dendritic growth promoting
effect is gelatinase-dependent
Some evidences suggest a growth promoting role of Sema3A for
cortical neuron dendrites [12]. We decided to culture dissociated
cortical neurons in the presence of purified Sema3A in order to
quantify this positive effect. The use of a double immunostaining
for axonal neurofilament (SMI312) and dendritic MAP2 allowed
us to discriminate between the two types of processes as early as
24 hours in culture. As expected, we found that the dendritic
length of cortical neurons were 40–60% increased with 100 ng/ml
Sema3A. Consistent with previous description of the inhibitory
function of Sema3A, this increase of dendritic length was
concomitant with a decrease of axonal length (data not shown).
To address the potential role of MMPs in the Sema3A-dependent
dendritic growth promotion, we used various pharmacological
inhibitors of MMPs (Figure 4). We, and others, previously
demonstrated the specificity of this strategy. Control experiments
(without Sema3A) revealed no change of dendritic length in the
presence of MMP inhibitors (see Figure S1). In the other hand, the
use of 1 mM GM6001, a large spectrum inhibitor of MMPs,
triggered a strong reduction of the Sema3A-growth promoting
effect. The growth promoting effect was conserved in the presence
of a specific inhibitor of MMP-3 that has been shown to suppress
the growth promoting effect of Sema3C for cortical axons [6]. On
the other hand, a gelatinase inhibitor (inhibitor of MMP-2 and
MMP-9) significantly reduced the dendritic growth promoting
effect of Sema3A. Thus, a gelatinase activity is required for the
Sema3A growth promoting effect. These data were obtained from
11 independent experiments with a total of 1837 neurons
analyzed.
Sema3A increases expression and activity of MMP-2
To characterize further the involvement of gelatinases in the
growth promoting effect of Sema3A, we performed western blot
analysis (4 independent experiments) and enzymatic activity assays
(3 independent experiments including triplicates of each experi-
mental condition). As depicted in Figure 5A, cortical neurons in
culture express both MMP-2 and MMP-9 consistently with RT-
PCR and in situ observations. The addition of Sema3A in the
culture medium induced 49% increase of MMP-2 expression while
MMP-9 expression remained unchanged. Thus, Sema3A triggers
a specific induction of MMP-2 expression. Using an Elisa-based
activity assay, we also found that the induction of MMP-2
expression was associated with an increased enzymatic activity
(+23%) in culture media while MMP-9 activity was not changed
(Figure 5B). These results demonstrate that Sema3A signalling
triggers a specific induction of MMP-2 expression and activity. To
demonstrate the specificity of the link between MMP-2 and
Sema3A we monitored MMP-2 activity in the presence of a
function-blocking antibody directed against Neuropilin-1, the
major binding receptor of Sema3A. To this end, cortical neurons
were grown in control conditions or in the presence of 100 ng/ml
Sema3A, with or without 1 mg/ml anti-NRP1. As expected from
previous studies, the selective blocking of NRP1 suppressed the
Sema3A-dependent growth promotion of cortical dendrites
(Figure 6A). Consistently, we found that blocking NRP1
suppressed Sema3A-induced augmentation of MMP-2 activity
(Figure 6B).
Sema3A-induced MMP-2 up-regulation is PKC dependent
Recent evidence suggests that semaphorins and MMPs share
common intracellular pathways. This has been shown for PKC, a
central regulator of signalling cascades [19]. To address the
question of the signalling mechanism linking Sema3A to MMP-2
we cultured neurons in the presence of the potent PKC inhibitor
Go ¨6976, which is supposed to be specific for the classical Ca
2+-
dependent isoforms. As illustrated in Figure 7A, the growth
promoting effect of Sema3A was abolished in cortical dendrites by
2.3 nM Go ¨. Moreover, Sema3A-dependent activation of MMP2 is
abolished in the presence 2.3 nM Go ¨. A western blot analysis
showed that PKC inhibition also blocked Sema3A-induced
MMP2 expression (Figure 8B, 3 independent experiments). No
change occurred at the transcriptional level (Figure 8A, 4
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Go ¨6976, our results are consistent with a role of PKC alpha to
trigger the growth promoting cascade of Sema3A. Thus, the
selective recruitment of MMP-2 to trigger Sema3A dendrite
growth promotion requires PKCa activation.
Discussion
Sema3A has been described as a chemottractant for the
dendrites of cortical neurons, a surprising effect in comparison
to the inhibitory effect of Sema3A in axons [12]. The molecular
mechanisms mediating this effect remain largely unknown. Based
on our previous finding of a role of MMP-3 in the growth and
guidance of cortical axons in response to the chemoattractive
Sema3C, we decided to investigate whether in the positive
semaphorin signalling, members of the MMP family would also
be involved. Our results provide evidence for a role of MMP-2 to
trigger the growth promoting effect of Sema3A. Because cortical
neurons express Sema3A, this mechanism is potentially cell
autonomous.
This result reinforces our previous observation suggesting a wide
implication of MMPs in the development of embryonic brain [6].
The use of in situ zymography showed that a gelatinolytic activity
is present in the entire thickness of the neocortex in dividing,
migrating or differentiating cells. The exact functions of MMPs
will have to be clarified in future studies. In the present study, we
focused on the proteolytic activity observed at the level of growing
dendrites. Unfortunately, no selective pharmacological inhibitors
were available to discriminate between MMP-2 and MMP-9, the
two major gelatinases. The one we used in our experiments blocks
completely MMP-2 and MMP-9 activity. In this case, the Sema3A
growth promoting effect on dendrites was only partially suppressed
suggesting that these two MMPs are not the only ones to be
involved. This was confirmed through the use of the large
spectrum MMP inhibitor GM6001 which was found to produce a
stronger reduction of the growth promoting effect of Sema3A.
Western blot analysis and ELISA-based activity assay using
specific antibodies against MMP-2 or MMP-9 showed that both
protein level and activity of MMP-2 but not MMP-9 were
increased in response to Sema3A. This is consistent with the strong
Figure 2. Expression of MMP2 and MMP9 in cortical neurons. (A) RT-PCR analysis of MMP2 and MMP9 transcripts in E15 whole brain, E15
whole cortex and dissociated E15 cortical neurons after 2 day in culture. GAPDH housekeeping gene was used as internal control for each sample
(bottom panel). B) RT-PCR analysis of Sema3A transcripts in cortical neurons. Molecular weight marker (GeneRuler
TM 100 bp DNA Ladder, Fermentas)
was used to check for correct transcript band (on left).
doi:10.1371/journal.pone.0005099.g002
Figure 1. Activity of MMPs in the developing cortex. (A–E) Quantification of the MMP activity revealed by in situ zymography performed with
FITC-conjugated gelatin. (A) Cytoarchitectural organization of the E15 neocortex visualized by semi thin section of E15 neocortex stained with
toluidin blue. (B, C, D) Representative microphotographs of in situ zymography performed with FITC-conjugated gelatin in control condition (B), in
the presence of 1,10-phenantroline (general MMP inhibitor) (C), and in the presence of a selective inhibitor of MMP-2/-9 (D). (E) Quantification of the
zymographic signals in the entire neocortex. (F–H) Co-localization of MMP-dependent gelatinolytic enzymatic activity (viewed by in situ zymography)
with MAP2 in E15 neocortex. (F) The immunostaining of the dendrites with anti-MAP2, (G) the corresponding zymographic signal and (H) the overlay
of the two images. (I) Higher magnification of the white selection box in the overlay. (H, I: white arrow indicates gelatinolytic activity surrounding
growing dendrites). MZ: Marginal Zone; CP: Cortical Plate; SP: Subplate zone; IZ: Intermediate Zone; SVZ: Sub-Ventricular Zone; VZ: Ventricular Zone.
doi:10.1371/journal.pone.0005099.g001
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localize with MAP2. A recent report also showed dendritic
expression of MMP-2 in E18 cortical dendrites [20]. In our model,
MMP-9 has no obvious effect. This contrasts with the results
obtained in the adult mice showing the involvement of MMP-9 for
dendritic remodelling following kaı ¨nate injection in the hippo-
campus [21]. MMP-9 is also known to regulate axon growth in the
cerebellum [22,23]. Taken together, these and our results indicate
that MMPs elicit cell-type and time-dependent biological functions
in the developing and mature brain. This is consistent with the
increasing demonstration of ADAM function in axon guidance
[24].
The receptor complex involved in the Sema3A-dependent
growth promotion has still to be clearly characterized. Our data
suggest that Sema3A-induced cortical dendrite outgrowth is
NRP1-dependent. The involvement of NRP1 is not surprising
because this receptor is the preferential binding partner of
Sema3A [25–28]. However, the composition of the receptor
complex allowing NRP1 to induce a growth promoting effect is
not known. In the zebrafish, the binding of Sema3D on a
homodimer of NRP1 induces repulsion while the binding of
Sema3D on a heterodimer composed of NRP1 and NRP2 induces
attraction [29]. We also have shown that the Sema3C-chemoat-
tractive effect on cortical axons requires NRP2 [6]. The exact role
of NRP1 and NRP2 homo and heterodimers has to be clarified in
this context. In any case, the functional link we discovered
between MMP-2 and Sema3A provides the second set of data
supporting the involvement of matrix metalloproteinase in
semaphorin signalling. Thus, as for netrins [18], ephrins [17,30]
or slit [31], a protease activity appears to be required to trigger
appropriate guidance cues signalling pathways, hence placing
proteolytic activity as a key actor of nervous system wiring. This is
consistent with recent data that showed in vivo the importance of
MMPs at decision points during the development of the optic
chiasm in Xenopus laevi [32].
The exact mechanism by which MMP-2 exerts Sema3A growth
promoting effect needs further investigation. We failed to detect
MMP-dependent receptor shedding to ensure the differential
effect of Sema3A in axon and dendrites. This mechanism is
considered as a very potent post-translational mechanism
regulating membrane receptors [33–35] and as already been
described for ADAMs, a subfamily of MMPs [33–35]. To better
understand the functional link between semaphorin and MMP-2
we also searched for some steps of the signalling pathways
involved. Several papers have described a positive link between
PKC activity and MMP-2 expression and activity in various cell
types [36–40]. Moreover, PKC signalling has been shown to
inhibit dendritic outgrowth in cerebellar Purkinje cells [41]. The
same group confirmed and extended this result; using KO-mice,
they showed the specific importance of PKCa and PKCc in the
Figure 4. MMP-dependent Sema3A-induced dendritic outgrowth. (A–B) Double staining on dissociated cortical neurons for neurofilament
(in green, as an axonal marker) and MAP2 (in red, as a dendritic marker) illustrating the decrease of axonal length and the increase of dendritic length
in presence (B) or not (A) of Sema3A. (C) Quantification of the dendritic growth promoting effect of Sema3A. Cortical neurons are grown without
treatment or with Sema3A + a large spectrum MMP inhibitor GM6001, or selective inhibitors of MMP-2/9 or MMP-3. (* p,0.01 student’s t test, ns not
significant).
doi:10.1371/journal.pone.0005099.g004
Figure 3. Expression of MMP2 at the apical dendrites of cortical neurons. Expression pattern of MMP-2 and MMP-9 in the mouse neocortex
at E15. (A–D) Microphotographs were obtained from confocal microscope analysis of the double staining (C) for MMP-2 (A), and MAP2 (as a dendritic
marker) in dendrites growing in the cortical plate (B). (D) Co localization profile of MMP-2 and MAP2 signals demonstrating the presence of MMP-2 in
the dendrites. (E–H) Confocal microscope images of the double staining (G) for MMP-9 (E) and MAP2 (F) in dendrites of the cortical plate. (H) Co
localization profile of MMP-9 and MAP2. Here the non-superposed graphs prove the absence of co localization between MMP-9 and MAP2. White
arrows point out representative line profiles allowing better visualization of double staining at the sub cellular level.
doi:10.1371/journal.pone.0005099.g003
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demonstrated the existence of a calcium-dependent pathway for
Sema3E (mouse semaphorin H) [45]. This semaphorin is
structurally very similar to Sema3A. It acts as a chemorepulsive
factor on sensory neurites [46,47] and triggers neurite outgrowth
in PC12 cells through an increase of the intracellular calcium level
[45,48]. More recently, the same group highlighted a similar
signalling pathway for another semaphorin, Sema4D [49]. In this
study, they described a PKC and calcium-dependent synergistic
neurotrophic effect between Sema4D and NGF in PC12 cells.
Finally, the group of Pfenninger has demonstrated that Sema3A-
induced growth cone detachment and collapse require activation
of PKC epsilon [50]. Our results show that the addition of the
general PKC blocker Go ¨6976 is sufficient to abolish the Sema3A
growth promoting effect and the increase of MMP-2 protein level
and activity without change at the transcriptional level. Thus, a
PKC-dependent pathway is activated upon Sema3A binding to
recruit MMP-2 and ensure dendrite outgrowth. Considering the
concentration of Go ¨6976 in our experiment (2.3 nM), this PKC
dependent mechanism should be mainly due to PKCa isoenzyme
[51,52].
In conclusion, we provide additional results implicating MMPs
in cortical development. We confirmed the functional link between
MMPs and Semaphorins by identifying MMP-2 as an effective
partner of Sema3A to trigger cortical dendrite outgrowth. This
functional growth promoting effect probably requires a PKCa-
dependent signalling pathway.
Materials and Methods
Cell culture
Cortical neurons were prepared from E15 mouse embryos as
previously described [53]. Cerebral hemispheres were dissected in
cold GBSS-glucose in order to isolate blocks of neocortex. They
Figure 5. Sema3A-dependent expression and activity of MMP-2. (A) Western Blotting analysis of MMP-2 and MMP-9 expression. The
expression of MMP-2 increases in the presence of Sema3A, while no modification occurs for MMP-9. (B) Determination of MMP-2 and MMP-9
enzymatic activity by ELISA assay. MMP-2 activity increases in the presence of Sema3A without modification MMP-9 activity. (* p,0.01 student’s t
test/control, ns not significant).
doi:10.1371/journal.pone.0005099.g005
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for 20 minutes, under agitation at 37uC. A volume of 5 ml of
culture medium with serum containing 2 mM L-glutamine, 1 mg/
ml glucose, 0.5 unit/ml penicillin, 0.5 mg/ml streptomycin, 10%
foetal bovine serum (FBS) in DMEM (Dulbecco’s modified Eagle
medium, Gibco), was added to stop the activity of trypsin. The cells
were centrifuged 5 minutes at 1000 g and the pellet was recovered
in 1 ml of culture medium with serum. The cells were mechanically
dissociated using a Gilson micropipette, filtered through 48 mm
diameter pores and centrifuged again. A cellular counting was
carried out and 2.10
5 cells were seeded on glass coverslips covered
with a substrate of poly-L-lysine (100 mg/ml). After 12 h in culture,
the culture medium was replaced with fresh serum-free medium
(2 mM L-glutamine, 1 mg/ml glucose, 0.5 unit/ml penicillin,
0.5 mg/ml streptomycin, 16 mg/ml putrescein, 52 ng/ml sodium
selenite, 10 mg/ml transferrin, 5 mg/ml insulin, 3 ng/ml progester-
one in DMEM). At this stage, neurons were treated with
pharmacological inhibitors of MMPs (the large spectrum inhibitor
of MMPs: GM6001, Calbiochem; MMP-2/MMP-9 Inhibitor I,
Calbiochem) or with Sema3A6inhibitors. In another set of
experiments, neurons were treated with function blocking anti-
bodies6Sema3A. Neurons were incubated with 1 mg/ml anti-
NRP1polyclonal antibody obtained using a synthetic14amino acid
peptide from the MAM domain of NRP1 [54,55]. We identified
axonal and dendritic processes by immunostaining of phosphory-
lated neurofilaments (SMI312, Steinberger Monoclonal, USA)
and/or MAP2 respectively (see immunocytochemistry section).
Axonal and dendritic length was determined using ImageJ software
implemented with the NeuronJ plugin. Purified Sema3A was
obtained as previously described [54]. Statistical analysis was
performed using student’s T test. Data are presented as mean +/2
standard errors. The number of experiments and/or number of
analyzed neurons is mentioned in the corresponding text.
Histology and immunocytochemistry
E15 mouse brains were fixed at 4uC for 24 h in a 4%
formaldehyde solution balanced with phosphate-buffered saline
(PBS: 140 mM NaCl+9m MN a 2HPO4, 2H2O+1.3 mM Na2PO4
H2O) and 20% sucrose. Fast freezing of the brains by direct
immersion in 245uC isopentane was carried out to prepare
sections for in situ zymography and double immunostainings.
These sections were prepared using a cryostat (Reichert-Jung,
LEICA). Slices were blocked in 3%-BSA-TBS for 30 minutes at
37uC, before overnight incubation at 4uC with primary antibodies
anti-MMP-2 or -9 from Chemicon International, Hampshire, UK,
ref. AB809 and ref. AB805 respectively, and/or anti-microtubule-
associated protein 2 (MAP2) from Sigma, Saint Quentin, France,
Ref. M4403, diluted in 3%-BSA-TBS, as a marker of dendrites.
MMP-2 or -9 and MAP2 signals were revealed using a secondary
antibody coupled with the avidin-biotin-fluorochrome Cy3
(Biosys, Compie `gne, France, ref. BI 4807 and Jackson ImmunoR-
esearch Laboratories, Suffolk, UK, ref. 016-160-084) or a
secondary antibody coupled with Alexa 488 (Molecular Probes,
Eugene, Oregon, ref. A-11017) respectively. Images were collected
using a confocal microscope (LSM510, Zeiss, Le Pecq, France).
Fluorescence profiles point out the presence or absence of co-
localization between the two markers in the dendrites. The arrow
shows a typical region across which line profiles were determined.
While not quantitative this representation helps to confirm visual
impressions of double staining.
In situ zymography
To determine the enzymatic activity of MMPs in situ, we applied
an adapted version (Gonthier et al., 2006) of the original method
described by Oh and collaborators [56] . We used fluorescein-
conjugated gelatin (from Enzcheck Assay kit, Molecular Probes,
ref. E_12055) as a substrate of gelatinases MMP-2/-9. In situ
Figure 6. Specificity of Sema3A-induced increase of MMP-2 activity. (A) Dissociated neurons were grown without treatment or in the
presence of Sema3A6blocking antibodies. The block of Neuropilin-1 (NRP1) suppressed Sema3A-induced dendritic growth. (B) Quantification of
MMP-2 activity in culture media from dissociated neurons treated or not with Sema3A6anti-NRP1. The block of Neuropilin-1 (NRP1) abolished
Sema3A-induced increase of MMP-2 activity. (* p,0.01 student’s t test/control, ns not significant).
doi:10.1371/journal.pone.0005099.g006
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thickness) prepared with a cryostat (Reichert-Jung, LEICA). The
sections were circled with a Dako Pen (DAKO) and incubated for
5 minutes with a reaction buffer (50 mM Tris-HCl+0.15 M
NaCl+5 mM CaCl2+0.2 mM sodium azide; pH 7.6). Reaction
mix consisting of 50 ml of reaction buffer +50 mg/ml of substrate
(FITC-gelatin) was added to the section for 24 h in a wet
darkroom, at 37uC. Negative control was obtained by the addition
of 50 mM 1,10- phenantrolin to the reaction solution. We also used
a potent inhibitor of MMP-2/-9 (Calbiochem, MMP-2/MMP-9
Inhibitor I, from VWR INTERNATIONAL S.A.S, Fontenay sous
Bois, France) at the final concentration of 1 mM. Sections were
mounted in Aqua Polymount (Poly Sciences, Eppelheim, Ger-
many) without washes. The observations were performed with an
inverted optical microscope (Axiovert 200M, Zeiss). The quanti-
fication of the fluorescence was determined using Metaview
(Universal Imaging Corporation, Evry, France). In some experi-
ments, in situ zymography was combined to immunohistochemis-
try. In this case, the zymographic reaction was performed during
primary antibody incubation (using anti-MAP2 antibody, see
details above), by addition of appropriate buffers.
Western blot analysis of MMP expression
Western blots were performed on fresh conditioned culture
media obtained from E15 dissociated cultured neurons. The
different fractions were probed with the same antibodies used for
immunohistochemistry (Chemicon International, ref. AB809 and
AB805). Samples migrated in 8% polyacrylamide gels for 2 h at
25 mA before transfer on a nitrocellulose membrane (PROTAN,
Perkin Elmer Life Sciences, ref. NBA085C) for 1 h at 250 mA.
Membranes were blocked in 5%-BSA-TBS for 30 min and
incubated with the primary antibody (dilution 1:5000 for MMP-
2 and 1:20000 for MMP-9) overnight at 4uC under agitation. After
several washes with TBS, the membranes were incubated with the
secondary antibody F(ab’)2 anti IgG (H+L) rabbit H.R.P.
(P.A.R.I.S., ref. BI 4407) at a dilution of 1:2000 in TBS for 1 h
at room temperature. After washing in TBS, the blots were
revealed with SuperSignal West Dura Extended Duration
Substrate (Pierce, Rockford, Illinois, ref. 34076). Protein concen-
tration was determined in the different samples by the Bradford
method. Equal loading was verified by red Ponceau staining of the
proteins in the absence of known referenced protein secreted at a
constant concentration in the culture medium.
RNA preparation and RT–PCR
Total RNA was extracted from freshly dissected E15 brain, E15
cortex and dissociated E15 cortical cell after 2 DIV. Dissociated
cortical neurons were seeded in 10-cm tissue culture dishes (Becton
Dickinson) covered with poly-L-lysine (100 mg/ml) at a concen-
tration of 5610
6 cells/box. After 12 h in culture, the culture
medium was changed with fresh serum-free medium (2 mM L-
glutamine, 1 mg/ml glucose, 0.5 unit/ml penicillin, and 2% B27
supplement from Invitrogen), and cells were treated or not with
Sema3A (100 ng/ml). RNA from the tissues and dissociated cells
was extracted by using Qiagen RNeasy Mini Kit. Genomic DNA
was eliminated by on-column DNase digestion according to
supplier recommendations. RNA concentration and quality were
assessed by spectrophotometry at 260 and 280 nm. cDNA was
generated using Super-Script III reverse transcriptase first strand
cDNA synthesis kit (Invitrogen). Briefly, 1 mg of total RNA was
reverse-transcribed using random primers and reverse transcrip-
tase (Invitrogen) and exposing the samples to 65uC for 5 min,
followed by 42uC for 60 min and 75uC for 15 min. Of the
resulting cDNA, 1 ml was used for transcript-specific PCR with
Figure 7. Sema3A growth promoting effect is PKC-dependent.
(A) Analysis of embryonic neurons dendritic length. Treatment of
dissociated neurons with 100 ng/ml of Sema3A and/or with Go ¨ 6976
increased dendritic length. (B) Analysis of MMP-2 activity by enzymatic
ELISA assay. Sema3A treatment increased MMP-2 activity in culture
media from cultured neurons. The inhibition of PKCa with 2.3 nM of Go ¨
suppressed the increase of MMP-2 activity induced by Sema3A.
(* p,0.01 student’s t test/control, ns not significant).
doi:10.1371/journal.pone.0005099.g007
Figure 8. Transcriptional and translational regulation of
Sema3A-induced MMP2 expression. The inhibition of PKCa blocks
Sema3A-induced MMP-2 at the protein level but not at the
transcriptional level. (A) RT-PCR analysis revealing no change of MMP-
2 expression at the transcription level. (B) Western blot analysis
revealing the lack of Sema3A-induced MMP-2 protein level augmenta-
tion in the presence of Go ¨ 6976 (translational effect).
doi:10.1371/journal.pone.0005099.g008
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sequences used for detection of MMP2, MMP9 and GAPDH were
59-CCGTGGATGATGCTTTTGCTCG-39/59-TCGTAGTT-
GGTTGTGGTCGC-39,5 9-GGACAGCCAGACACTAAAGG-
39/59-AGGAAGACGAAGGGGAAGAC-39 59-CGGTGCTGAG-
TATGTCGTG-39/59-GTTATTATGGGGGTCTGGGATG-39
respectively. 59-GAGGGAGCAGGATTAGAGTC-39/59-AGA-
GAGGCAGTCAGTAGTTTGGG-39 for Sema3A. PCR was
performed incubating samples for 3 min at 94uC and then cycling
35 times for 30 s at 94uC, 30 s at 58uC, and 1 min at 72uC,
followed by final elongation at 72uC for 5 min. Expression of
GAPDH was used as PCR amplification positive control. Negative
control for amplification consisted of RNA processed without the
addition of reverse transcriptase. PCR products were subjected to
electrophoresis on 1% TAE agarose gels containing ethidium
bromide and visualized with UV light.
MMP ELISA activity assays
Specific MMP enzymatic activities were determined as
previously described [6,57] in conditioned media using the Matrix
Metalloproteinase Biotrak Activity Assay System for MMP-2 and -
9 (Amersham Biosciences, Buckinghamshire, UK, ref. RPN2631
and ref. RPN2634 respectively). The whole procedure to measure
the total activity of MMPs was performed according to
manufacturer’s instructions. Briefly, Elisa plates were incubated
with culture media overnight at 4uC. The plates were then washed
and incubated with a reaction solution containing a specific
substrate of the matching MMP at 37uC and APMA (p-
Aminophenylmercuric acetate) to activate all the pro-MMPs.
Supporting Information
Figure S1
Found at: doi:10.1371/journal.pone.0005099.s001 (0.14 MB TIF)
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